ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

0RN3 Takeda Pharmaceutical Co Ltd

49.35
0.00 (0.00%)
19 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Takeda Pharmaceutical Co Ltd LSE:0RN3 London Ordinary Share JP3463000004 TAKEDA PHARMACEUTICAL ORD SHS
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 49.35 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 4.05T 317.02B 200.3525 0.13 40.78B

Wellington Management Group LLP Form 8.3 - Takeda Pharmaceutical Company Limited (5782K)

14/12/2018 3:05pm

UK Regulatory


Takeda Pharmaceutical (LSE:0RN3)
Historical Stock Chart


From Apr 2019 to Apr 2024

Click Here for more Takeda Pharmaceutical Charts.

TIDMSHP TIDM0RN3

RNS Number : 5782K

Wellington Management Group LLP

14 December 2018

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 
1.         KEY INFORMATION 
 
 (a)   Full name of discloser:                                                                       Wellington Management Group LLP 
 (b)   Owner or controller of interests and 
        short positions disclosed, if different 
        from 1(a): 
        The naming of nominee or vehicle companies 
        is insufficient. For a trust, the trustee(s), 
        settlor and beneficiaries must be named. 
----  --------------------------------------------------------------------------------------------  --------------------------------------------------------------- 
 (c)   Name of offeror/offeree in relation to                                                        Takeda Pharmaceutical Company 
        whose relevant securities this form relates:                                                  Limited 
        Use a separate form for each offeror/offeree 
----  --------------------------------------------------------------------------------------------  --------------------------------------------------------------- 
 (d)   If an exempt fund manager connected with 
        an offeror/offeree, state this and specify 
        identity of offeror/offeree: 
----  --------------------------------------------------------------------------------------------  --------------------------------------------------------------- 
 (e)   Date position held/dealing undertaken:                                                        13 December 2018 
        For an opening position disclosure, state 
        the latest practicable date prior to 
        the disclosure 
----  --------------------------------------------------------------------------------------------  --------------------------------------------------------------- 
 (f)   In addition to the company in 1(c) above,                                                     YES 
        is the discloser making disclosures in                                                        Shire PLC 
        respect of any other party to the offer? 
        If it is a cash offer or possible cash 
        offer, state "N/A" 
----  --------------------------------------------------------------------------------------------  --------------------------------------------------------------- 
 
2.         POSITIONS OF THE PERSON MAKING THE DISCLOSURE 
If there are positions or rights to subscribe to disclose in more than 
 one class of relevant securities of the offeror or offeree named in 1(c), 
 copy table 2(a) or (b) (as appropriate) for each additional class of relevant 
 security. 
(a)        Interests and short positions in the relevant securities of the offeror 
            or offeree to which the disclosure relates following the dealing (if 
            any) 
 
 Class of relevant security:                                Common Stock (JP3463000004) 
                                                                                      Interests                                         Short Positions 
                                                                                                                            --------------------------------------- 
                                                                              Number                             %                    Number                 % 
                                                                                                                            --------------------------  ----------- 
       Relevant securities owned 
 (1)    and/or controlled:                                  17,680,297                                              2.22 %   63,799                          0.01 % 
                                                           -------------------------------------------  ------------------  --------------------------  ----------- 
 (2)   Cash-settled derivatives: 
----  ---------------------------------------------------  -------------------------------------------  ------------------  --------------------------  ----------- 
 (3)   Stock-settled derivatives 
        (including options) and 
        agreements to purchase/sell: 
----  ---------------------------------------------------  -------------------------------------------  ------------------  --------------------------  ----------- 
       Total                                                17,680,297 *                                            2.22 %   63,799                          0.01 % 
----  ---------------------------------------------------  -------------------------------------------  ------------------  --------------------------  ----------- 
 *Wellington Management Group LLP does not have discretion regarding voting 
  decisions in respect of 13,581,683 shares that are included in the total 
  above. 
All interests and all short positions should be disclosed. 
 Details of any open stock-settled derivative positions (including traded 
 options), or agreements to purchase or sell relevant securities, should 
 be given on a Supplemental Form 8 (Open Positions). 
 
(b)        Rights to subscribe for new securities (including directors' and other 
            employee options) 
 
 Class of relevant security 
  in relation to which subscription 
  right exists: 
 Details, including nature of 
  the rights concerned and relevant 
  percentages: 
                                                           -------------------------------------------------------------------------------------------------------- 
 
3.         DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE 
Where there have been dealings in more than one class of relevant securities 
 of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) 
 (as appropriate) for each additional class of relevant security dealt in. 
 The currency of all prices and other monetary amounts should be stated. 
(a)        Purchases and sales 
 
          Class of relevant security                       Purchase/sale                             Number of securities                      Price per unit 
 Common Stock (JP3463000004)                    Purchase                               1,800                                              3,980.3611 JPY 
                                               -------------------------------------  -------------------------------------------------  -------------------------- 
 Common Stock (JP3463000004)                    Sale                                   1,200                                              3,980.0000 JPY 
                                               -------------------------------------  -------------------------------------------------  -------------------------- 
 Common Stock (JP3463000004)                    Sale                                   5,600                                              3,880.3125 JPY 
                                               -------------------------------------  -------------------------------------------------  -------------------------- 
 
(b)        Cash-settled derivative transactions 
 
      Class of relevant                Product description                         Nature of dealing                         Number of               Price per 
           security                          e.g. CFD                             e.g. opening/closing                        reference                 unit 
                                                                                 a long/short position,                      securities 
                                                                                   increasing/reducing 
                                                                                  a long/short position 
 
 
(c)        Stock-settled derivative transactions (including options) 
 
(i)        Writing, selling, purchasing or varying 
 
  Class of relevant        Product           Writing,              Number of                   Exercise                 Type e.g.           Expiry      Option money 
       security           description       purchasing,            securities                  price per                 American,           date       paid/ received 
                           e.g. call          selling,              to which                      unit                   European                          per unit 
                            option            varying            option relates                                            etc. 
                                                etc. 
 
 
(ii)       Exercise 
 
          Class of relevant                  Product description                    Exercising/                  Number of securities           Exercise price 
               security                        e.g. call option                  exercised against                                                  per unit 
 
 
(d)        Other dealings (including subscribing for new securities) 
 
          Class of relevant security                     Nature of dealing                                 Details                           Price per unit (if 
                                                         e.g. subscription,                                                                      applicable) 
                                                             conversion 
 
 
4.         OTHER INFORMATION 
 
(a)        Indemnity and other dealing arrangements 
 
 Details of any indemnity or option arrangement, or any agreement or understanding, 
  formal or informal, relating to relevant securities which may be an inducement 
  to deal or refrain from dealing entered into by the person making the disclosure 
  and any party to the offer or any person acting in concert with a party 
  to the offer: 
  Irrevocable commitments and letters of intent should not be included. If 
  there are no such agreements, arrangements or understandings, state "none" 
 None 
 
(b)        Agreements, arrangements or understandings relating to options or 
            derivatives 
 
 Details of any agreement, arrangement or understanding, formal or informal, 
  between the person making the disclosure and any other person relating 
  to: 
  (i) the voting rights of any relevant securities under any option; or 
  (ii) the voting rights or future acquisition or disposal of any relevant 
  securities to which any derivative is referenced: 
  If there are no such agreements, arrangements or understandings, state 
  "none" 
 None 
 
(c)        Attachments 
 
 Is a Supplemental Form 8 (Open Positions)                                                     NO 
  attached? 
 
 Date of disclosure                                                                            14 December 2018 
 Contact name                                                                                  Meredith Smart 
                                                                                              --------------------------------------------------------------------- 
 Telephone number                                                                              44-20-7126-6311 
                                                                                              --------------------------------------------------------------------- 
 
 
 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

RETGGGUUPUPRGAC

(END) Dow Jones Newswires

December 14, 2018 10:05 ET (15:05 GMT)

1 Year Takeda Pharmaceutical Chart

1 Year Takeda Pharmaceutical Chart

1 Month Takeda Pharmaceutical Chart

1 Month Takeda Pharmaceutical Chart

Your Recent History

Delayed Upgrade Clock